ロード中...
Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission
Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) has been accepted as a treatment option for aggressive (acute or lymphoma type) adult T cell leukemia/lymphoma (ATLL) patients with a poor prognosis, when a suitable HLA-matched donor is not available. However, haplo-HSCT carries a...
保存先:
| 出版年: | Ann Hematol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7060159/ https://ncbi.nlm.nih.gov/pubmed/32006150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-03934-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|